Holding a basic seminar on Tangential Flow Filtration (TFF) that can be learned from scratch!
The new business fields related to the manufacturing of biopharmaceuticals, such as gene therapy drugs, peptide medicines, and new types of vaccines represented by mRNA vaccines, are on a continuous path of expansion. However, the technology for scaling up from lab-scale to commercial production scale remains a challenge. The equipment and operating methods used in small-scale lab production differ from those used in commercial production scale. Therefore, while leveraging the results of laboratory-level research, it is essential to collect test data that anticipates the transition to GMP manufacturing from the preclinical and clinical trial drug production stages. This will be the first step toward practical application in the future. This seminar will provide an overview of the fundamentals of TFF technology, which is frequently used in manufacturing processes. Date: November 25, 2021 (Thursday) 13:30 ~ 14:30 *An on-demand version is currently available. URL: https://biotech.pall.jp/jp/ja/landing/tff-basics.html?utm_source=e_signature&utm_medium=email&utm_campaign=21-11-121-TFFWB-JP&utm_content=text_link_lab
Inquire About This Product
basic information
We will hold a webinar related to Tangential Flow Filtration (TFF). This is a must-attend for those who want to gain insights into TFF technology!
Price information
Please contact us.
Delivery Time
※Please contact us.
Applications/Examples of results
For details, please see the webinar.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.